Annual EBIT
-$303.82 M
-$4.26 M-1.42%
31 December 2023
Summary:
Pacific Biosciences of California annual earnings before interest & taxes is currently -$303.82 million, with the most recent change of -$4.26 million (-1.42%) on 31 December 2023. During the last 3 years, it has fallen by -$333.49 million (-1123.98%). PACB annual EBIT is now -1123.98% below its all-time high of $38.97 million.PACB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$57.19 M
+$112.59 M+66.32%
30 September 2024
Summary:
Pacific Biosciences of California quarterly earnings before interest & taxes is currently -$57.19 million, with the most recent change of +$112.59 million (+66.32%) on 30 September 2024. Over the past year, it has increased by +$16.80 million (+22.71%). PACB quarterly EBIT is now -176.32% below its all-time high of $74.94 million, reached on 31 December 2020.PACB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$380.73 M
+$16.80 M+4.23%
30 September 2024
Summary:
Pacific Biosciences of California TTM earnings before interest & taxes is currently -$380.73 million, with the most recent change of +$16.80 million (+4.23%) on 30 September 2024. Over the past year, it has dropped by -$75.34 million (-24.67%). PACB TTM EBIT is now -1383.22% below its all-time high of $29.67 million, reached on 31 December 2020.PACB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.4% | +22.7% | -24.7% |
| 3 y3 years | -1124.0% | +23.5% | -209.6% |
| 5 y5 years | -203.4% | -101.0% | -239.1% |
PACB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1124.0% | at low | at high | +66.3% | -209.6% | +4.2% |
| 5 y | 5 years | -1124.0% | at low | -176.3% | +66.3% | -1383.2% | +4.2% |
| alltime | all time | -1124.0% | at low | -176.3% | +66.3% | -1383.2% | +4.2% |
Pacific Biosciences Of California EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$57.19 M(-66.3%) | -$380.73 M(-4.2%) |
| June 2024 | - | -$169.78 M(+127.6%) | -$397.53 M(+35.2%) |
| Mar 2024 | - | -$74.60 M(-5.8%) | -$294.03 M(-3.2%) |
| Dec 2023 | -$303.82 M(+1.4%) | -$79.17 M(+7.0%) | -$303.82 M(-0.5%) |
| Sept 2023 | - | -$73.99 M(+11.6%) | -$305.39 M(+0.2%) |
| June 2023 | - | -$66.28 M(-21.5%) | -$304.71 M(-0.5%) |
| Mar 2023 | - | -$84.39 M(+4.5%) | -$306.30 M(+2.1%) |
| Dec 2022 | -$299.56 M(+14.2%) | -$80.74 M(+10.1%) | -$299.87 M(+5.8%) |
| Sept 2022 | - | -$73.31 M(+8.0%) | -$283.43 M(-0.5%) |
| June 2022 | - | -$67.87 M(-12.9%) | -$284.88 M(+12.0%) |
| Mar 2022 | - | -$77.95 M(+21.2%) | -$254.42 M(-3.0%) |
| Dec 2021 | -$262.34 M(-984.2%) | -$64.30 M(-14.0%) | -$262.19 M(+113.2%) |
| Sept 2021 | - | -$74.76 M(+99.8%) | -$122.96 M(+71.0%) |
| June 2021 | - | -$37.41 M(-56.4%) | -$71.91 M(+24.9%) |
| Mar 2021 | - | -$85.72 M(-214.4%) | -$57.58 M(-294.1%) |
| Dec 2020 | $29.67 M(-136.4%) | $74.94 M(-416.1%) | $29.67 M(-166.4%) |
| Sept 2020 | - | -$23.71 M(+2.7%) | -$44.68 M(-9.6%) |
| June 2020 | - | -$23.09 M(-1609.9%) | -$49.43 M(-1.7%) |
| Mar 2020 | - | $1.53 M(+160.5%) | -$50.30 M(-38.3%) |
| Dec 2019 | -$81.52 M(-18.6%) | $587.00 K(-102.1%) | -$81.52 M(-27.4%) |
| Sept 2019 | - | -$28.46 M(+18.8%) | -$112.28 M(+3.7%) |
| June 2019 | - | -$23.95 M(-19.4%) | -$108.25 M(+1.9%) |
| Mar 2019 | - | -$29.70 M(-1.6%) | -$106.24 M(+6.1%) |
| Dec 2018 | -$100.14 M(+12.2%) | -$30.17 M(+23.5%) | -$100.14 M(+11.1%) |
| Sept 2018 | - | -$24.43 M(+11.3%) | -$90.11 M(+3.5%) |
| June 2018 | - | -$21.94 M(-7.0%) | -$87.07 M(-3.1%) |
| Mar 2018 | - | -$23.60 M(+17.2%) | -$89.84 M(+0.6%) |
| Dec 2017 | -$89.27 M(+25.5%) | -$20.14 M(-5.8%) | -$89.27 M(+2.2%) |
| Sept 2017 | - | -$21.39 M(-13.5%) | -$87.32 M(+5.7%) |
| June 2017 | - | -$24.71 M(+7.3%) | -$82.61 M(+9.3%) |
| Mar 2017 | - | -$23.03 M(+26.6%) | -$75.60 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$71.14 M(+147.3%) | -$18.19 M(+9.1%) | -$71.14 M(+32.8%) |
| Sept 2016 | - | -$16.67 M(-5.8%) | -$53.59 M(+56.0%) |
| June 2016 | - | -$17.70 M(-4.7%) | -$34.35 M(+23.3%) |
| Mar 2016 | - | -$18.57 M(+2820.3%) | -$27.87 M(-3.1%) |
| Dec 2015 | -$28.77 M(-54.6%) | -$636.00 K(-124.8%) | -$28.77 M(-38.0%) |
| Sept 2015 | - | $2.56 M(-122.8%) | -$46.38 M(-19.2%) |
| June 2015 | - | -$11.22 M(-42.4%) | -$57.39 M(-11.2%) |
| Mar 2015 | - | -$19.48 M(+6.7%) | -$64.61 M(+2.0%) |
| Dec 2014 | -$63.33 M(-17.6%) | -$18.25 M(+116.1%) | -$63.33 M(+2.8%) |
| Sept 2014 | - | -$8.45 M(-54.2%) | -$61.62 M(-15.6%) |
| June 2014 | - | -$18.43 M(+1.3%) | -$72.97 M(-1.8%) |
| Mar 2014 | - | -$18.20 M(+10.0%) | -$74.34 M(-3.2%) |
| Dec 2013 | -$76.81 M(-18.4%) | -$16.54 M(-16.5%) | -$76.81 M(-6.2%) |
| Sept 2013 | - | -$19.80 M(+0.0%) | -$81.88 M(-3.4%) |
| June 2013 | - | -$19.80 M(-4.3%) | -$84.74 M(-3.0%) |
| Mar 2013 | - | -$20.68 M(-4.3%) | -$87.36 M(-7.3%) |
| Dec 2012 | -$94.19 M(-13.7%) | -$21.60 M(-4.7%) | -$94.19 M(-0.5%) |
| Sept 2012 | - | -$22.66 M(+1.1%) | -$94.62 M(-6.7%) |
| June 2012 | - | -$22.42 M(-18.5%) | -$101.40 M(-0.2%) |
| Mar 2012 | - | -$27.51 M(+24.9%) | -$101.64 M(-6.8%) |
| Dec 2011 | -$109.10 M(-22.2%) | -$22.03 M(-25.1%) | -$109.10 M(-11.8%) |
| Sept 2011 | - | -$29.44 M(+29.9%) | -$123.66 M(-8.3%) |
| June 2011 | - | -$22.66 M(-35.2%) | -$134.91 M(-6.9%) |
| Mar 2011 | - | -$34.97 M(-4.4%) | -$144.93 M(+3.3%) |
| Dec 2010 | -$140.23 M(+59.2%) | -$36.59 M(-10.1%) | -$140.23 M(+6.5%) |
| Sept 2010 | - | -$40.70 M(+24.5%) | -$131.72 M(+14.0%) |
| June 2010 | - | -$32.67 M(+7.9%) | -$115.59 M(+39.4%) |
| Mar 2010 | - | -$30.27 M(+7.8%) | -$82.92 M(+57.5%) |
| Dec 2009 | -$88.07 M(+96.5%) | -$28.07 M(+14.3%) | -$52.64 M(+114.3%) |
| Sept 2009 | - | -$24.57 M | -$24.57 M |
| Dec 2008 | -$44.81 M(+91.6%) | - | - |
| Dec 2007 | -$23.39 M | - | - |
FAQ
- What is Pacific Biosciences of California annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual EBIT year-on-year change?
- What is Pacific Biosciences of California quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly EBIT year-on-year change?
- What is Pacific Biosciences of California TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pacific Biosciences of California?
- What is Pacific Biosciences of California TTM EBIT year-on-year change?
What is Pacific Biosciences of California annual earnings before interest & taxes?
The current annual EBIT of PACB is -$303.82 M
What is the all time high annual EBIT for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual earnings before interest & taxes is $38.97 M
What is Pacific Biosciences of California annual EBIT year-on-year change?
Over the past year, PACB annual earnings before interest & taxes has changed by -$4.26 M (-1.42%)
What is Pacific Biosciences of California quarterly earnings before interest & taxes?
The current quarterly EBIT of PACB is -$57.19 M
What is the all time high quarterly EBIT for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly earnings before interest & taxes is $74.94 M
What is Pacific Biosciences of California quarterly EBIT year-on-year change?
Over the past year, PACB quarterly earnings before interest & taxes has changed by +$16.80 M (+22.71%)
What is Pacific Biosciences of California TTM earnings before interest & taxes?
The current TTM EBIT of PACB is -$380.73 M
What is the all time high TTM EBIT for Pacific Biosciences of California?
Pacific Biosciences of California all-time high TTM earnings before interest & taxes is $29.67 M
What is Pacific Biosciences of California TTM EBIT year-on-year change?
Over the past year, PACB TTM earnings before interest & taxes has changed by -$75.34 M (-24.67%)